-
Tesaro
-
AstraZeneca
-
Bristol_Myers_Squibb
-
Novartis
-
Celgene
-
Genentech
-
Amgen
-
Eisai
Low Level Laser Therapy
Low-level laser therapy (LLLT) involves the use of a hand-held infrared laser in an attempt to affect cells and physical symptoms often related to inflammation. The therapy has been approved by the Food and Drug Administration for treatment of post-mastectomy lymphedema. LLLT has also been evaluated for prevention and treatment of mucositis.
Low Level Laser Therapy in Patients Undergoing Hematopoietic Cell Transplantation
Low level laser therapy (LLLT) involves the use of a handheld infrared laser in an attempt to affect cells and physical symptoms often related to inflammation. This therapy has been approved by the U.S. Food and Drug Administration for treatment of post-mastectomy lymphedema. LLLT has also been evaluated for the prevention and treatment of mucositis in patients receiving stem cell transplantation conditioning or radiation therapy to the oral cavity area.